Cargando…
A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery
Therapeutic effects of anticancer medicines can be improved by targeting the specific receptors on cancer cells. Folate receptor (FR) targeting with antibody (Ab) is an effective tool to deliver anticancer drugs to the cancer cell. In this research project, a novel formulation of targeting drug deli...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747068/ https://www.ncbi.nlm.nih.gov/pubmed/35011493 http://dx.doi.org/10.3390/molecules27010261 |
_version_ | 1784630741251915776 |
---|---|
author | Lodhi, Madeeha Shahzad Khalid, Fatima Khan, Muhammad Tahir Samra, Zahoor Qadir Muhammad, Shabbir Zhang, Yu-Juan Mou, Kejie |
author_facet | Lodhi, Madeeha Shahzad Khalid, Fatima Khan, Muhammad Tahir Samra, Zahoor Qadir Muhammad, Shabbir Zhang, Yu-Juan Mou, Kejie |
author_sort | Lodhi, Madeeha Shahzad |
collection | PubMed |
description | Therapeutic effects of anticancer medicines can be improved by targeting the specific receptors on cancer cells. Folate receptor (FR) targeting with antibody (Ab) is an effective tool to deliver anticancer drugs to the cancer cell. In this research project, a novel formulation of targeting drug delivery was designed, and its anticancer effects were analyzed. Folic acid-conjugated magnetic nanoparticles (MNPs) were used for the purification of folate receptors through a novel magnetic affinity purification method. Antibodies against the folate receptors and methotrexate (MTX) were developed and characterized with enzyme-linked immunosorbent assay and Western blot. Targeting nanomedicines (MNP-MTX-FR Ab) were synthesized by engineering the MNP with methotrexate and anti-folate receptor antibody (anti-FR Ab). The cytotoxicity of nanomedicines on HeLa cells was analyzed by calculating the % age cell viability. A fluorescent study was performed with HeLa cells and tumor tissue sections to analyze the binding efficacy and intracellular tracking of synthesized nanomedicines. MNP-MTX-FR Ab demonstrated good cytotoxicity along all the nanocomposites, which confirms that the antibody-coated medicine possesses the potential affinity to destroy cancer cells in the targeted drug delivery process. Immunohistochemical approaches and fluorescent study further confirmed their uptake by FRs on the tumor cells’ surface in antibody-mediated endocytosis. The current approach is a useful addition to targeted drug delivery for better management of cancer therapy along with immunotherapy in the future. |
format | Online Article Text |
id | pubmed-8747068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87470682022-01-11 A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery Lodhi, Madeeha Shahzad Khalid, Fatima Khan, Muhammad Tahir Samra, Zahoor Qadir Muhammad, Shabbir Zhang, Yu-Juan Mou, Kejie Molecules Article Therapeutic effects of anticancer medicines can be improved by targeting the specific receptors on cancer cells. Folate receptor (FR) targeting with antibody (Ab) is an effective tool to deliver anticancer drugs to the cancer cell. In this research project, a novel formulation of targeting drug delivery was designed, and its anticancer effects were analyzed. Folic acid-conjugated magnetic nanoparticles (MNPs) were used for the purification of folate receptors through a novel magnetic affinity purification method. Antibodies against the folate receptors and methotrexate (MTX) were developed and characterized with enzyme-linked immunosorbent assay and Western blot. Targeting nanomedicines (MNP-MTX-FR Ab) were synthesized by engineering the MNP with methotrexate and anti-folate receptor antibody (anti-FR Ab). The cytotoxicity of nanomedicines on HeLa cells was analyzed by calculating the % age cell viability. A fluorescent study was performed with HeLa cells and tumor tissue sections to analyze the binding efficacy and intracellular tracking of synthesized nanomedicines. MNP-MTX-FR Ab demonstrated good cytotoxicity along all the nanocomposites, which confirms that the antibody-coated medicine possesses the potential affinity to destroy cancer cells in the targeted drug delivery process. Immunohistochemical approaches and fluorescent study further confirmed their uptake by FRs on the tumor cells’ surface in antibody-mediated endocytosis. The current approach is a useful addition to targeted drug delivery for better management of cancer therapy along with immunotherapy in the future. MDPI 2022-01-01 /pmc/articles/PMC8747068/ /pubmed/35011493 http://dx.doi.org/10.3390/molecules27010261 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lodhi, Madeeha Shahzad Khalid, Fatima Khan, Muhammad Tahir Samra, Zahoor Qadir Muhammad, Shabbir Zhang, Yu-Juan Mou, Kejie A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery |
title | A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery |
title_full | A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery |
title_fullStr | A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery |
title_full_unstemmed | A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery |
title_short | A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery |
title_sort | novel method of magnetic nanoparticles functionalized with anti-folate receptor antibody and methotrexate for antibody mediated targeted drug delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747068/ https://www.ncbi.nlm.nih.gov/pubmed/35011493 http://dx.doi.org/10.3390/molecules27010261 |
work_keys_str_mv | AT lodhimadeehashahzad anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT khalidfatima anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT khanmuhammadtahir anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT samrazahoorqadir anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT muhammadshabbir anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT zhangyujuan anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT moukejie anovelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT lodhimadeehashahzad novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT khalidfatima novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT khanmuhammadtahir novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT samrazahoorqadir novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT muhammadshabbir novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT zhangyujuan novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery AT moukejie novelmethodofmagneticnanoparticlesfunctionalizedwithantifolatereceptorantibodyandmethotrexateforantibodymediatedtargeteddrugdelivery |